ALA — Arovella Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- AU$61.65m
- AU$47.30m
- AU$0.80m
Annual cashflow statement for Arovella Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.528 | 1.08 | 2.07 | 3.69 | 4.3 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.27 | -6.4 | -6.91 | -6.93 | -6.91 |
| Capital Expenditures | -0.566 | -0.003 | -0.129 | -0.413 | -0.039 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | 0.098 | -0.05 | -0.019 | -0.001 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.566 | 0.095 | -0.179 | -0.432 | -0.04 |
| Financing Cash Flow Items | — | — | — | -1.29 | -0.018 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.19 | 5.41 | 14.6 | 15.5 | 0.489 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.646 | -0.896 | 7.54 | 8.16 | -6.52 |